Highly doubtful. If they didn't have enough to serve a measly 300 people , how could they claim to the FDA to have any stockpile of Ryoncil on Sep 30 approval to allow immediate treatment, I think that is a pre-requisite of approval.
Now that they are moving the manufacturing into one of the US labs, that also has a couple of massive - 2000 and 1000 liter bioreactors.... getting enough treatment is not going to be an issue - it has never been identified by the company as being an issue. They pay lonza, and lonza produce. ?
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C, page-225
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
-0.010(0.99%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.00 | $709.7K | 704.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 97501 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 43186 | 16 |
View Market Depth
| Last trade - 11.32am 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |